JDJoel Sanabria Duarte

Joel Sanabria Duarte

*This is an algorithmically generated author record based on publicly available information.

Joel Sanabria Duarte has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Safety and efficacy of microsurgical decompression for 6 arachnoid bands

    by Igor Baroni Cardoso, Lara Mensato Döring, Anna Caroline Ulson da Costa, Lucas Cesar Werneck, Emannuel Lucas Machado da Silva, Joel Sanabria, José Lucas Malosti Teodoro Rodrigues, Afonso Henrique de Aragão, Leonardo Gilmone Ruschel

    Background: Dorsal spinal arachnoid bands are a rare cause of focal spinal cord compression and thoracic myelopathy that alter cerebrospinal fluid dynamics and may lead to progressive neurological deficits and syringomyelia. Nevertheless, the clinical outcomes of surgical treatment remain incompletely characterized. Here, we evaluated the safety and clinical outcomes of 6 microsurgical decompressions for dorsal thoracic arachnoid bands in a single-center cohort. Methods: Six patients underwent surgery for dorsal thoracicspinal arachnoid bands with/without syringomyelia (2021–2025) at a single center. Demographic, diagnostic, and surgical reports and outcomes were assessed. Surgical decompressions utilized microsurgical techniques and intraoperative neurophysiological monitoring. Results: Six patients averaged 49.3 years of age, and four were female. T6 was the most involved thoracic level. Surgery included mostly hemilaminectomies addressing 6 arachnoid bands and 4 syrinxes. Postoperatively, 5 patients improved, while one remained unchanged. Only one postoperative adverse event occurred: pneumonia. Postoperative magnetic resonance studies documented complete arachnoid band/syrinx resolution. Conclusion: Microsurgical decompression of dorsal spinal arachnoid bands is both safe and effective.

  • Open Access

    A reproducible deep dorsal root entry zone lesioning technique for cervical root avulsion: Outcomes from a clinical series

    by Leonardo Gilmone Ruschel, Igor Baroni Cardoso, Anna Caroline Ulson da Costa, Lucas Cesar Werneck, Luiz Daniel Penzo, Afonso Henrique Aragão, Joel Sanabria Duarte

    Background: Neuropathic pain following traumatic cervical root avulsion remains a major clinical challenge when conservative therapies fail. Ablative neurosurgical procedures such as dorsal root entry zone (DREZ) lesioning continue to play a role in this refractory population. We present our experience with a standardized, reproducible microsurgical deep DREZ technique and compare outcomes with those reported in the literature. Methods: We conducted a retrospective series of six patients with intractable neuropathic pain due to root avulsion, treated between 2021 and 2025 at a tertiary referral center in Southern Brazil. All surgeries were performed microsurgically under intraoperative neurophysiological monitoring. Lesions were made at a fixed depth of 4–5 mm targeting Rexed laminae I–VI. Pre and postoperative pain intensity was assessed using the Visual Analog Scale (VAS); postoperative analgesic use and complications were also recorded. Results were contextualized against published data from both superficial and deep DREZ approaches. Results: Postoperative VAS scores ranged from 0 to 3, corresponding to a 66.7–100% reduction in pain; two patients (33.3%) achieved complete pain abolition. Four patients (66.7%) discontinued analgesic medication entirely. The remaining two patients maintained reduced – but altered – pain patterns compared with baseline. No permanent neurological deficits, cerebrospinal fluid leaks, infections, or autonomic disturbances occurred. One patient had a wound dehiscence that was successfully managed. These outcomes are comparable with modern deep DREZ series and appear superior to those historically reported for superficial techniques. Conclusion: A microsurgical standardized deep DREZ lesioning technique targeting laminae I–VI demonstrates high efficacy, reproducibility, and a favorable safety profile for the management of refractory neuropathic pain after cervical root avulsion. Our findings support the adoption of this reproducible technique in specialized centers, although larger prospective studies are necessary to confirm long-term durability across institutions.

  • Open Access

    Intraoperative neurophysiological mapping of trigeminal nerve: A surgical advancement in neurovascular decompression

    by Joel Sanabria Duarte, Daniel Benzecry de Almeida, Gabriella Mara Arcie, Mauricio Coelho Neto, Murilo Sousa de Meneses, Ricardo Ramina


  • 5-Aminolevulinic acid fluorescence in brain non-neoplastic lesions: a systematic review and case series

    by Joel F. Sanabria Duarte, Gustavo S. Jung, Erasmo Barros da Silva, Bernardo Corrêa de Almeida Teixeira, Marcela Santos Cavalcanti, Ricardo Ramina

    Fluorescence-guided surgery with 5-aminolevulinic acid (5-ALA) is used to assist brain tumor resection, especially for high-grade gliomas but also for low-grade gliomas, metastasis, and meningiomas. With the increasing use of this technique, even to assist biopsies, high-grade glioma–mimicking lesions had misled diagnosis by showing 5-ALA fluorescence in non-neoplastic lesions such as radiation necrosis and inflammatory or infectious disease. Since only isolated reports have been published, we systematically review papers reporting non-neoplastic lesion cases with 5-ALA according with the PRISMA guidelines, present our series, and discuss its pathophysiology. In total, 245 articles were identified and 12 were extracted according to our inclusion criteria. Analyzing 27 patients, high-grade glioma was postulated as preoperative diagnosis in 48% of the cases. Microsurgical resection was performed in 19 cases (70%), while 8 patients were submitted to biopsy (30%). We found 4 positive cases in demyelinating disease (50%), 4 in brain abscess (80%), 1 in neurocysticercosis (33%), 1 in neurotoxoplasmosis, infarction, and hematoma (100%), 4 in inflammatory disease (80%), and 3 in cortical dysplasia (100%). New indications are being considered especially in benign lesion biopsies with assistance of 5-ALA. Using fluorescence as an aid in biopsies may improve procedure time, number of samples, and necessity of intraoperative pathology. Further studies should include this technology to encourage more beneficial uses.


  • Open Access

    CGRP: from history to clinical application - A review

    by Afonso Henrique Aragao, Joel Sanabria Duarte, Daniel Benzecry Almeida, Ricardo Ramina

    The role of calcitonin gene-related peptide (CGRP) and its receptor have played an important role in migraine for the last decades due to development of therapies that target their receptors at the trigeminal pain system, aiming at prevention or relief of acute migraine attacks. At first, CGRP receptor antagonists, called gepants have demonstrated appropriate effectiveness. In addition, they did not cause vasoconstriction, one of the drawbacks of triptans. However, their use had to be discontinued due to the risk of liver toxicity. Humanized monoclonal antibodies towards CGRP and the CGRP receptor have been developed as an alternative approach to block CGRP transmission. Still, there are some questions not fully answered as where CGRP and its receptor are located, how they influence the mechanisms of migraine attacks and if the blood brain barrier has any sort of importance. There is still much to learn about CGRP and migraine pathophysiology, especially its anatomical target sites and anti-CGRP agents. This paper presents a review of CGRP, including a brief history, focusing in CGRP mechanism, updates and future treatments.